Companies sponsors |
Theramex (abaloparatide) |
Others |
Department of Health and Social Care |
|
Health Technology Wales (HTW) |
|
NHS England |
Patient carer groups |
Royal Osteoporosis Society |
Professional groups |
Royal College of Physicians |
|
Royal College of Radiologists |
Assessment group |
School of Health and Related Research (ScHARR) |
Associated public health groups |
None |
Comparator companies |
Accord Healthcare (alendronic acid, ibandronic acid, teriparatide) (confidentiality agreement not signed, not participating) |
|
Accord-UK (raloxifene, risedronate sodium) (confidentiality agreement not signed, not participating) |
|
Amgen (denosumab) (confidentiality agreement not signed, not participating) |
|
Aristo Pharma (risedronate sodium, strontium ranelate) (confidentiality agreement not signed, not participating) |
|
Aspire Pharma (ibandronic acid, raloxifene, risedronate sodium) (confidentiality agreement not signed, not participating) |
|
Atnahs Pharma (ibandronic acid) (confidentiality agreement not signed, not participating) |
|
Aurobindo Pharma - Milpharm (alendronic acid, risedronate sodium) (confidentiality agreement not signed, not participating) |
|
Dr. Reddy's Laboratories (zoledronic acid) (confidentiality agreement not signed, not participating) |
|
Eli Lilly (teriparatide) (confidentiality agreement not signed, not participating) |
|
Gedeon Richter (teriparatide) (confidentiality agreement not signed, not participating) |
|
Internis Pharmaceuticals (alendronic acid) (confidentiality agreement not signed, not participating) |
|
Mylan (ibandronic acid) (confidentiality agreement not signed, not participating) |
|
Novartis (zoledronic acid) (confidentiality agreement not signed, not participating) |
|
Organon Pharma (alendronic acid) (confidentiality agreement not signed, not participating) |
|
Ranbaxy (UK) Limited a Sun Pharmaceutical Company (zoledronic acid) (confidentiality agreement not signed, not participating) |
|
Rosemont (alendronic acid) (confidentiality agreement not signed, not participating) |
|
Sandoz (risedronate sodium, ibandronic acid) (confidentiality agreement not signed, not participating) |
|
Seacross Pharmaceuticals (zoledronic acid) (confidentiality agreement not signed, not participating) |
|
Teva UK (teriparatide) (confidentiality agreement not signed, not participating) |
|
Thornton & Ross (teriparatide) (confidentiality agreement not signed, not participating) |
|
UCB Pharma (romosozumab) (confidentiality agreement not signed, not participating) |
|
Vygoris (raloxifene) (confidentiality agreement not signed, not participating) |
|
Zentiva (ibandronic acid) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
National Institute of Health Research |